Skip to content

Bain Capital Investors LLC

Follow

13F filer, CIK 1040508, Boston, MA

Bain Capital Investors LLC reported $4,754,892,080 across 8 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-462000

Period
2026-09-30
Reported value
$4.75B
Holdings
8
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Bain Capital Life Sciences Investors, LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • ADCT ADC THERAPEUTICS SA: 13G 14,825,625 shares, 9.99% of the class, 13G filed 2026-10-29, 0001193125-26-438199Timeline
    Accepted , ingested

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-462000, largest first. % of portfolio is the value over $4,754,892,080, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BOBSBOBS DISC FURNITURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,370,751 shares; 2026Q2: 95,370,751 shares; 2026Q3: 95,370,751 shares 95,370,751$1.32B27.8%0Timeline
AVAHAVEANNA HEALTHCARE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 81,600,880 shares; 2025Q1: 81,600,880 shares; 2025Q2: 81,600,880 shares; 2025Q3: 81,600,880 shares; 2025Q4: 81,600,880 shares; 2026Q1: 81,600,880 shares; 2026Q2: 81,600,880 shares; 2026Q3: 81,600,880 shares 81,600,880$1.01B21.3%0Timeline
KMTSKESTRA MED TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 27,019,225 shares; 2025Q2: 27,019,225 shares; 2025Q3: 27,019,225 shares; 2025Q4: 25,172,338 shares; 2026Q1: 25,172,338 shares; 2026Q2: 25,172,338 shares; 2026Q3: 25,172,338 shares 25,172,338$712M14.98%0Timeline
SGRYSURGERY PARTNERS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 49,946,972 shares; 2025Q1: 49,946,972 shares; 2025Q2: 49,946,972 shares; 2025Q3: 49,946,972 shares; 2025Q4: 49,946,972 shares; 2026Q1: 49,946,972 shares; 2026Q2: 49,946,972 shares; 2026Q3: 49,946,972 shares 49,946,972$693M14.57%02026-10-23, 13D/A: 30,055,197 shares, 22.96% of the class, 13D/A filed 2026-10-26 Timeline
NTNXNUTANIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,854,032 shares; 2025Q1: 10,960,935 shares; 2025Q2: 5,355,285 shares; 2025Q3: 5,355,285 shares; 2025Q4: 5,355,285 shares; 2026Q1: 5,355,285 shares; 2026Q2: 5,355,285 shares; 2026Q3: 5,355,285 shares 5,355,285$377M7.93%0Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 27,980,417 shares; 2025Q1: 21,754,536 shares; 2025Q2: 18,055,049 shares; 2025Q3: 13,243,539 shares; 2025Q4: 13,243,539 shares; 2026Q1: 13,243,539 shares; 2026Q2: 13,243,539 shares; 2026Q3: 13,243,539 shares 13,243,539$336M7.06%0Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,255,581 shares; 2026Q3: 26,255,581 shares 26,255,581$300M6.31%0Timeline
ADVADVANTAGE SOLUTIONS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 115,600 shares; 2026Q2: 115,600 shares; 2026Q3: 115,600 shares 115,600$3M0.06%0Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-462000 base2026-11-16